Auriga Upgrades Myriad Genetics (MYGN) to Buy; Patience Will Be Rewarded
Tweet Send to a Friend
Auriga upgraded Myriad Genetics (NASDAQ: MYGN) to Buy with a price target of $24.00.
Auriga analyst says, "For Myriad, FY12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Auriga analyst says, "For Myriad, FY12 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
